Next Financial Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-500
Closed 2591
2016
Q3
$0 Hold
500
﹤0.01% 2532
2016
Q2
$0 Hold
500
﹤0.01% 1963
2016
Q1
$0 Hold
500
﹤0.01% 1998
2015
Q4
$0 Sell
500
-4,000
-89% ﹤0.01% 2076
2015
Q3
$7K Hold
4,500
﹤0.01% 1349
2015
Q2
$7K Hold
4,500
﹤0.01% 1414
2015
Q1
$6K Hold
4,500
﹤0.01% 1459
2014
Q4
$7K Hold
4,500
﹤0.01% 1417
2014
Q3
$9K Buy
+4,500
New +$9K ﹤0.01% 1847

Next Financial Group's RXII Position: Q4 2016 in Review

Next Financial Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 500 shares.

Next Financial Group first reported a position in RXII in Q3 2014 and held it in 9 quarters. The position peaked at $9K in Q3 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Next Financial Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Next Financial Group sold 500 GALENA BIOPHARMA INC COM shares in Q4 2016.
  • Next Financial Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2014 and held it in 9 quarters.
  • Next Financial Group's GALENA BIOPHARMA INC COM position peaked at $9K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Next Financial Group's 13F filing for Q4 2016, filed 2 Feb 2017.